blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2303268

EP2303268 - PHARMACEUTICAL COMPOSITIONS BASED ON KININ B2 RECEPTOR ANTAGONISTS AND CORTICOSTEROIDS, AND THEIR USE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.04.2013
Database last updated on 18.11.2024
Most recent event   Tooltip27.04.2018Change - lapse in a contracting state
State(s) deleted from list of lapses: CY
published on 30.05.2018  [2018/22]
Applicant(s)For all designated states
Istituto Luso Farmaco d'Italia S.p.A.
Via Walter Tobagi, 8
20068 Peschiera Borromeo / IT
[2011/14]
Inventor(s)01 / GIULIANI, Sandro
Via Carlo Borrani 11
I-50012 Bagno A Ripoli (FI) / IT
02 / MAGGI, Carlo, Alberto
Borgo Tegolaio 15
I-50125 Firenze / IT
 [2011/14]
Representative(s)Banfi, Paolo
Bianchetti & Minoja with
Trevisan & Cuonzo IPS Srl
Via Plinio, 63
20129 Milano / IT
[N/P]
Former [2012/25]Banfi, Paolo
Bianchetti Bracco Minoja S.r.l. Via Plinio, 63
20129 Milano / IT
Former [2011/14]Banfi, Paolo
Bianchetti Bracco Minoja S.r.l. Via Plinio, 63
20129 Milano / IT
Application number, filing date09793880.703.07.2009
[2011/14]
WO2009EP04847
Priority number, dateIT2008MI0126411.07.2008         Original published format: IT MI20081264
[2011/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010003601
Date:14.01.2010
Language:EN
[2010/02]
Type: A1 Application with search report 
No.:EP2303268
Date:06.04.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 14.01.2010 takes the place of the publication of the European patent application.
[2011/14]
Type: B1 Patent specification 
No.:EP2303268
Date:20.06.2012
Language:EN
[2012/25]
Search report(s)International search report - published on:EP14.01.2010
ClassificationIPC:A61K31/437, A61K31/4709, A61K31/496, A61K31/573, A61K38/08, A61P19/02
[2011/14]
CPC:
A61K31/573 (EP,KR,US); A61K31/437 (EP,KR,US); A61K31/4709 (EP,KR,US);
A61K31/496 (EP,KR,US); A61P11/00 (EP); A61P11/02 (EP);
A61P11/06 (EP); A61P11/08 (EP); A61P17/00 (EP);
A61P17/02 (EP); A61P17/04 (EP); A61P17/06 (EP);
A61P19/00 (EP); A61P19/02 (EP); A61P19/08 (EP);
A61P27/02 (EP); A61P27/14 (EP); A61P29/00 (EP);
A61P37/08 (EP); A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/14]
Extension statesAL03.01.2011
BA03.01.2011
RS03.01.2011
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNGEN AUF BASIS VON KININ-B2-REZEPTORANTAGONISTEN UND CORTICOSTEROIDEN SOWIE IHRE VERWENDUNG[2012/03]
English:PHARMACEUTICAL COMPOSITIONS BASED ON KININ B2 RECEPTOR ANTAGONISTS AND CORTICOSTEROIDS, AND THEIR USE[2011/14]
French:COMPOSITIONS PHARMACEUTIQUES À BASE D ANTAGONISTES DU RÉCEPTEUR B2 DE LA KININE ET DE CORTICOSTÉROÏDES ET LEUR UTILISATION[2011/14]
Former [2011/14]PHARMAZEUTISCHE ZUSAMMENSETZUNGEN AUS BASIS VON KININ-B2-REZEPTORANTAGONISTEN UND CORTICOSTEROIDEN SOWIE IHRE VERWENDUNG
Entry into regional phase03.01.2011National basic fee paid 
03.01.2011Designation fee(s) paid 
03.01.2011Examination fee paid 
Examination procedure23.03.2010Request for preliminary examination filed
International Preliminary Examining Authority: EP
03.01.2011Examination requested  [2011/14]
28.12.2011Communication of intention to grant the patent
29.03.2012Fee for grant paid
29.03.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.12.2011
Opposition(s)21.03.2013No opposition filed within time limit [2013/22]
Fees paidRenewal fee
25.07.2011Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipSM20.06.2012
MC31.07.2012
[2018/22]
Former [2018/17]CY20.06.2012
SM20.06.2012
MC31.07.2012
Former [2016/35]CY20.06.2012
SM20.06.2012
MC31.07.2012
Former [2014/27]CY20.06.2012
SM20.06.2012
MC31.07.2012
Former [2013/11]CY20.06.2012
MC31.07.2012
Former [2013/10]CY20.06.2012
Cited inInternational search[A]WO03000696  (METAPHORE PHARMACEUTICALS INC [US], et al) [A] * claims 23-26 *;
 [A]WO2004069266  (AVENTIS PHARMA GMBH [DE]) [A] * page 1, paragraph 1 * * page 7, paragraph 3 *;
 [A]WO2006040004  (LUSO FARMACO INST [IT], et al);
 [A]WO2007003411  (JERINI AG [DE], et al) [A] * claims 4,5 *;
 [X]EP1894559  (PARI PHARMA GMBH [DE]) [X] 1-8,10,11 * claims 19,20,40 *;
 [A]  - SHARMA, JAGDISH N. ET AL, "Inhibition of rats adjuvant arthritis by a bradykinin antagonist Hoe 140 and its influence on kallikreins", GENERAL PHARMACOLOGY , 27(1), 133-6 CODEN: GEPHDP; ISSN: 0306-3623, (1996), XP008105253 [A] * figure 1 * * page 135, column 2, paragraph 5 *

DOI:   http://dx.doi.org/10.1016/0306-3623(95)00078-X
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.